DISCLOSEDQuarterly
Renaissance Technologies
Neurocrine Biosciences Inc · NASDAQ
2,335,897 sh · $393.7M
Filed 30 Jun 2026SEC 13Fview source
BlackRock
13F filer
$1.95B
14,190,708 sh
Dodge & Cox
13F filer
$941.2M
5,584,707 sh
Renaissance Technologies
13F filer
$393.7M
2,335,897 sh
Two Sigma Investments
13F filer
$349.9M
2,076,260 sh
Bridgewater Associates
13F filer
$34.7M
205,677 sh
Renaissance Technologies
Neurocrine Biosciences Inc · NASDAQ
2,335,897 sh · $393.7M
Dodge & Cox
Neurocrine Biosciences Inc · NASDAQ
5,584,707 sh · $941.2M
Two Sigma Investments
Neurocrine Biosciences Inc · NASDAQ
2,076,260 sh · $349.9M
Bridgewater Associates
Neurocrine Biosciences Inc · NASDAQ
205,677 sh · $34.7M
Renaissance Technologies
Neurocrine Biosciences Inc · NASDAQ
2,418,897 sh · $318.7M
Dodge & Cox
Neurocrine Biosciences Inc · NASDAQ
5,461,037 sh · $719.4M
Bridgewater Associates
Neurocrine Biosciences Inc · NASDAQ
148,141 sh · $19.5M
Two Sigma Investments
Neurocrine Biosciences Inc · NASDAQ
3,060,570 sh · $403.2M
Bridgewater Associates
Neurocrine Biosciences Inc · NASDAQ
149,990 sh · $21.3M
Renaissance Technologies
Neurocrine Biosciences Inc · NASDAQ
2,238,797 sh · $317.5M